<?xml version="1.0" ?>
<GlossaryTerm id="CDR0000635785">
  <TermName>EPOCH</TermName>
  <TermDefinition>
    <DefinitionText>An abbreviation for a chemotherapy combination used to treat aggressive forms of non-Hodgkin lymphoma, including mantle cell lymphoma. It includes the drugs etoposide phosphate, prednisone, vincristine sulfate (Oncovin), cyclophosphamide, and doxorubicin hydrochloride (hydroxydaunorubicin). Also called EPOCH regimen.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </TermDefinition>
  <MediaLink ref="CDR0000734708" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;EPOCH&quot;" language="en" id="_3"/>
  <SpanishTermName>EPOCH</SpanishTermName>
  <SpanishTermDefinition>
    <DefinitionText>Nombre de  una quimioterapia combinada que se usa para el tratamiento de formas agresivas (crecimiento rápido) del linfoma no Hodgkin, como el linfoma de células del manto. Incluye los medicamentos fosfato de etopósido, prednisona, sulfato de vincristina (Oncovin), ciclofosfamida y clorhidrato de doxorrubicina (hidroxidaunorrubicina).   También se llama régimen EPOCH.</DefinitionText>
    <Dictionary>Cancer.gov</Dictionary>
    <Audience>Patient</Audience>
  </SpanishTermDefinition>
  <DateFirstPublished>2009-02-23</DateFirstPublished>
  <DateLastModified>2010-05-05</DateLastModified>
  <RelatedInformation>
    <RelatedDrugSummaryRef UseWith="en" href="CDR0000634872" url="/about-cancer/treatment/drugs/EPOCH">EPOCH</RelatedDrugSummaryRef>
  </RelatedInformation>
</GlossaryTerm>
